SAGENT PHARMACEUTICALS INC's ticker is SGNT and the CUSIP is 786692103. A total of 128 filers reported holding SAGENT PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 0.07 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2016 | $279,000 | -23.4% | 22,994 | +0.4% | 0.01% | -29.4% |
Q4 2015 | $364,000 | -1.4% | 22,894 | -5.0% | 0.02% | +21.4% |
Q3 2015 | $369,000 | -72.7% | 24,094 | -56.7% | 0.01% | -68.9% |
Q2 2015 | $1,353,000 | +49.7% | 55,687 | +43.2% | 0.04% | +45.2% |
Q1 2015 | $904,000 | -5.3% | 38,883 | +2.2% | 0.03% | -13.9% |
Q4 2014 | $955,000 | +17.8% | 38,044 | +9.6% | 0.04% | -16.3% |
Q1 2014 | $811,000 | +25.7% | 34,719 | +36.6% | 0.04% | +26.5% |
Q4 2013 | $645,000 | -31.3% | 25,422 | -44.8% | 0.03% | -33.3% |
Q3 2013 | $939,000 | +115.4% | 46,056 | +121.4% | 0.05% | +264.3% |
Q2 2013 | $436,000 | – | 20,802 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Timpani Capital Management LLC | 110,215 | $2,248,000 | 1.32% |
Healthcare Value Capital, LLC | 73,822 | $1,506,000 | 1.32% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,014,863 | $20,703,000 | 0.96% |
Perimeter Capital Partners, LLC | 248,893 | $5,077,000 | 0.94% |
Tekla Capital Management LLC | 270,031 | $5,509,000 | 0.61% |
SECTORAL ASSET MANAGEMENT INC | 564,325 | $11,512,000 | 0.55% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 168,268 | $3,432,000 | 0.35% |
MENTA CAPITAL LLC | 30,480 | $622,000 | 0.32% |
KOPP INVESTMENT ADVISORS LLC | 39,934 | $815,000 | 0.30% |
Broadfin Capital, LLC | 68,300 | $1,393,000 | 0.25% |